These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2306678)
1. An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Hongo T; Fujii Y; Igarashi Y Cancer; 1990 Mar; 65(6):1263-72. PubMed ID: 2306678 [TBL] [Abstract][Full Text] [Related]
2. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513 [TBL] [Abstract][Full Text] [Related]
3. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616 [TBL] [Abstract][Full Text] [Related]
4. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias. Kravtsov VD; Greer JP; Whitlock JA; Koury MJ Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366 [TBL] [Abstract][Full Text] [Related]
5. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376 [TBL] [Abstract][Full Text] [Related]
6. In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. Klumper E; Pieters R; Kaspers GJ; Huismans DR; Loonen AH; Rottier MM; van Wering ER; van der Does-van den Berg A; Hählen K; Creutzig U Leukemia; 1995 Nov; 9(11):1864-9. PubMed ID: 7475276 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid resistance in childhood leukemia. Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644 [TBL] [Abstract][Full Text] [Related]
9. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294 [TBL] [Abstract][Full Text] [Related]
10. MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report. Karakaş Z; Ağaoğlu L; Erdem S; Anak S; Hacibektaşoğlu A; Gedikoğlu G Adv Exp Med Biol; 1999; 457():453-9. PubMed ID: 10500822 [No Abstract] [Full Text] [Related]
11. [Anticancer drug sensitivity test using the short-term microplate culture and MTT dye reduction assay]. Hongo T; Fujii Y; Mizuno Y; Haraguchi S; Yoshida TO Gan To Kagaku Ryoho; 1987 Feb; 14(2):472-8. PubMed ID: 2434030 [TBL] [Abstract][Full Text] [Related]
12. In vitro chemosensitivity testing in acute leukemias. Results of a retrospective study. Lepri E; Liberati M; Menconi E; Santucci A; Piselli F; Barzi A Anticancer Res; 1990; 10(6):1735-8. PubMed ID: 2285251 [TBL] [Abstract][Full Text] [Related]
13. In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay. Hongo T; Fujii Y Int J Hematol; 1991 Jun; 54(3):219-30. PubMed ID: 1747457 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of blast cell sensitivity to low-intensity laser radiation and chemotherapeutic drugs]. Karu TI; Riabykh TP; Sidorova TA; Dobrynin IaV Dokl Akad Nauk; 1997 Mar; 353(1):114-7. PubMed ID: 9273047 [No Abstract] [Full Text] [Related]
15. A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Cooper TM; Cassar J; Eckroth E; Malvar J; Sposto R; Gaynon P; Chang BH; Gore L; August K; Pollard JA; DuBois SG; Silverman LB; Oesterheld J; Gammon G; Magoon D; Annesley C; Brown PA Clin Cancer Res; 2016 Aug; 22(16):4014-22. PubMed ID: 26920889 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. von Stackelberg A; Seeger K; Henze G; Eckert C Leukemia; 2004 Oct; 18(10):1727-8; author reply 1728-9. PubMed ID: 15356653 [No Abstract] [Full Text] [Related]
17. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia]. Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919 [No Abstract] [Full Text] [Related]
18. Circumvention of glucocorticoid resistance in childhood leukemia. Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253 [TBL] [Abstract][Full Text] [Related]
19. Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Steinherz PG; Shukla N; Kobos R; Steinherz L Pediatr Blood Cancer; 2010 May; 54(5):687-93. PubMed ID: 20205253 [TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of blast cell proliferation and effectiveness of combined chemotherapy in children with different immunocytological subvariants of acute lymphoblastic and nonlymphoblastic leukemia]. Golenko OD; Tupitsyn NN; Protasova AK; Balakirev SA; Kochetkova OD Gematol Transfuziol; 1989 Sep; 34(9):24-8. PubMed ID: 2583457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]